CORD-19:775b90287b44353bee979abb0970a4666022f86d / 704948-705184
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Similar percentages of adults and children/adolescents receiving the 300IR sublingual tablets withdrew from the studies due to TEAEs (49 [4.7%] adults and 7 [4.5%] children/adolescents), mainly as a result of application site reactions.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T19139","span":{"begin":0,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T19139","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T234","span":{"begin":0,"end":236},"obj":"Sentence"}],"attributes":[{"subj":"T234","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1460","span":{"begin":75,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A1460","pred":"uberon_id","subj":"T1460","obj":"http://purl.obolibrary.org/obo/UBERON_2001275"},{"subj":"T1460","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecc093","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a693ec"},{"id":"CORD-19-PD-UBERON","color":"#99ec93"}]}]}}